$BDPT
BIOADAPTIVES, INC.

2021 Form 10-K Financial Statement

#000164033422000689 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $19.78K $3.730K $16.33K
YoY Change 21.12% 221.55% 64.42%
Cost Of Revenue $9.671K $2.130K $10.23K
YoY Change -5.48% -23.66% 102.61%
Gross Profit $10.11K $1.600K $6.095K
YoY Change 65.79% -198.16% 24.9%
Gross Profit Margin 51.1% 42.9% 37.33%
Selling, General & Admin $512.4K $19.43K $260.4K
YoY Change 96.76% -76.81% 8.83%
% of Gross Profit 5070.76% 1214.38% 4272.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $133.8K
YoY Change
% of Gross Profit 1324.0%
Operating Expenses $646.2K $19.43K $260.4K
YoY Change 148.13% -76.81% 8.83%
Operating Profit -$636.1K -$17.83K -$254.3K
YoY Change 150.1% -79.13% 8.5%
Interest Expense $272.4K -$147.6K $230.3K
YoY Change 18.26% 1222.58% -5195.75%
% of Operating Profit
Other Income/Expense, Net $413.9K $592.9K
YoY Change -30.2%
Pretax Income -$1.050M -$165.4K -$847.2K
YoY Change 23.93% 71.24% 254.6%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.050M -$165.4K -$847.2K
YoY Change 23.93% 71.24% 254.6%
Net Earnings / Revenue -5309.2% -4434.85% -5189.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$31.12K -$7.998K -$41.56K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.13K $5.030K $5.030K
YoY Change 1552.68% -61.57% -61.57%
Cash & Equivalents $4.587K
Short-Term Investments $190.00 $440.00 $440.00
Other Short-Term Assets $1.000K
YoY Change
Inventory $4.750K $13.82K $13.82K
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $88.88K $18.85K $18.85K
YoY Change 371.51% -22.16% -22.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $59.71K $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $88.88K $18.85K $18.85K
Total Long-Term Assets $59.71K $0.00 $0.00
Total Assets $148.6K $18.85K $18.85K
YoY Change 688.28% -22.16% -22.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $247.8K $87.56K
YoY Change 182.95% 192.35%
Accrued Expenses $46.15K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $436.8K $483.0K $483.0K
YoY Change -9.55% 30.49% 30.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.242M $1.398M $1.398M
YoY Change -11.16% 61.75% 61.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.242M $1.398M $1.398M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.242M $1.398M $1.398M
YoY Change -11.16% 61.75% 61.75%
SHAREHOLDERS EQUITY
Retained Earnings -$5.606M
YoY Change
Common Stock $2.159K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.093M -$1.379M -$1.379M
YoY Change
Total Liabilities & Shareholders Equity $148.6K $18.85K $18.85K
YoY Change 688.28% -22.16% -22.14%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$1.050M -$165.4K -$847.2K
YoY Change 23.93% 71.24% 254.6%
Depreciation, Depletion And Amortization $133.8K
YoY Change
Cash From Operating Activities -$158.7K -$9.860K -$106.9K
YoY Change 48.43% -87.09% -36.42%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $237.0K 0.000 $99.16K
YoY Change 139.0% -100.0% -20.17%
NET CHANGE
Cash From Operating Activities -$158.7K -9.860K -$106.9K
Cash From Investing Activities
Cash From Financing Activities $237.0K 0.000 $99.16K
Net Change In Cash $78.35K -9.860K -$7.726K
YoY Change -1114.1% -181.09% -82.4%
FREE CASH FLOW
Cash From Operating Activities -$158.7K -$9.860K -$106.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
77715 USD
CY2021 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2020Q4 us-gaap Cash
Cash
4587 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
444 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
13815 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
827119 USD
CY2021Q4 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
13333 USD
CY2020Q4 bdpt Convertible Notes Net Of Discount
ConvertibleNotesNetOfDiscount
4764 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50819780 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21591942 shares
CY2021Q4 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
10000 shares
CY2020Q4 bdpt Common Stock Capital Shares Reserved For Future Issuance1
CommonStockCapitalSharesReservedForFutureIssuance1
762390 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2159 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4225217 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5606161 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1093039 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
148585 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18846 USD
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
557042 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
444 USD
CY2020 us-gaap Revenues
Revenues
16327 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
10232 USD
CY2020 us-gaap Gross Profit
GrossProfit
6095 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
72409 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
48369 USD
CY2021 bdpt Stock Based Compensation
StockBasedCompensation
163900 USD
CY2020 bdpt Stock Based Compensation
StockBasedCompensation
139643 USD
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
133791 USD
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
646186 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
260421 USD
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-254 USD
CY2020 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-328 USD
CY2021 us-gaap Interest Expense
InterestExpense
272394 USD
CY2020 us-gaap Interest Expense
InterestExpense
230328 USD
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-90219 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-362262 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Other Expenses
OtherExpenses
413867 USD
CY2020 us-gaap Other Expenses
OtherExpenses
592918 USD
CY2021 us-gaap Income Loss From Subsidiaries Before Tax
IncomeLossFromSubsidiariesBeforeTax
-1049948 USD
CY2020 us-gaap Income Loss From Subsidiaries Before Tax
IncomeLossFromSubsidiariesBeforeTax
-847244 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1049948 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-847244 USD
CY2021 bdpt Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.03
CY2020 bdpt Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.04
CY2021 bdpt Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
33742920 shares
CY2020 bdpt Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
20387798 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-839876 USD
CY2020 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
168692 USD
CY2020 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
47115 USD
CY2020 bdpt Common Stock Issued For Service Related Party Amount
CommonStockIssuedForServiceRelatedPartyAmount
72000 USD
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
20528 USD
CY2020 bdpt Cancellation Of Common Stock Officers Amount
CancellationOfCommonStockOfficersAmount
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-847244 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1378785 USD
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
75000 USD
CY2021 us-gaap Preferred Stock Redemption Discount
PreferredStockRedemptionDiscount
193500 USD
CY2021 bdpt Common Stock Issued For Conversion Of Debt Amount
CommonStockIssuedForConversionOfDebtAmount
856627 USD
CY2021 bdpt Common Stock Issued For Service Amount
CommonStockIssuedForServiceAmount
163900 USD
CY2021 bdpt Cancellation Of Common Stock Officers Amount
CancellationOfCommonStockOfficersAmount
0 USD
CY2021 bdpt Adjustments To Additional Paid In Capital Other Debts Forgiveness Related Party
AdjustmentsToAdditionalPaidInCapitalOtherDebtsForgivenessRelatedParty
46667 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1049948 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1093039 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1049948 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-847244 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
163900 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
47115 USD
CY2021 bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
0 USD
CY2020 bdpt Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
92528 USD
CY2020 us-gaap Separate Account Liability Period Increase Decrease
SeparateAccountLiabilityPeriodIncreaseDecrease
0 USD
CY2021 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
90219 USD
CY2020 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
362262 USD
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
133791 USD
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
216931 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
179843 USD
CY2021 bdpt Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
51000 USD
CY2020 bdpt Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
0 USD
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
254 USD
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
328 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9065 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2687 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
227137 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
60966 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158651 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-106889 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
9800 USD
CY2021 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2020 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-18352 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1623 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1623 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2021 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0 USD
CY2020 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
27715 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
257000 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
80000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
237000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
99163 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
78349 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7726 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4587 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12313 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82936 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4587 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
16424 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1079 USD
CY2021 us-gaap Separate Account Liability Period Increase Decrease
SeparateAccountLiabilityPeriodIncreaseDecrease
205000 USD
CY2021 bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
856627 USD
CY2020 bdpt Issuance Of Common Stock For Conversion Of Debt
IssuanceOfCommonStockForConversionOfDebt
168692 USD
CY2021 us-gaap Proceeds From Issuance Of Trust Preferred Securities
ProceedsFromIssuanceOfTrustPreferredSecurities
193500 USD
CY2020 us-gaap Proceeds From Issuance Of Trust Preferred Securities
ProceedsFromIssuanceOfTrustPreferredSecurities
0 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
46667 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
CY2021 us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
35 USD
CY2020 us-gaap Treasury Stock Retired Par Value Method Amount
TreasuryStockRetiredParValueMethodAmount
56 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company, and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
82936 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
4587 USD
CY2021 bdpt Schedule Of Diluted Net Lossper Sharepolicytextblock
ScheduleOfDilutedNetLossperSharepolicytextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> (Shares) </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> (Shares) </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Series A Preferred Stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Convertible notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">57,513,358</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">36,247,341</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">65,513,358</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">36,247,341</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
65513358 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36247341 shares
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
190 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
557042 USD
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
444 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
827119 USD
CY2021Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
166666 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
68341 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
49583 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
10993 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
24845 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
247750 USD
CY2021 bdpt Beginning Balance
BeginningBalance
827119 USD
CY2021 bdpt Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
205000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6656109 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
190 USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
1750 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
5374 USD
CY2021Q4 bdpt Credit Card
CreditCard
0 USD
CY2020Q4 bdpt Credit Card
CreditCard
7759 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
87561 USD
CY2021Q4 bdpt Convertible Notes Payable Before Unamortized Debt Discount
ConvertibleNotesPayableBeforeUnamortizedDebtDiscount
416450 USD
CY2020Q4 bdpt Convertible Notes Payable Before Unamortized Debt Discount
ConvertibleNotesPayableBeforeUnamortizedDebtDiscount
410000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13333 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4764 USD
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
403117 USD
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
405236 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
403117 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
405236 USD
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
53660 USD
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
46779 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63100 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46145 USD
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
216931 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
179843 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
271050 USD
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
358697 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
205000 USD
CY2021 bdpt Loss On Derivative Instruments Related To Convertible Notes
LossOnDerivativeInstrumentsRelatedToConvertibleNotes
153697 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
239593 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
107000 USD
CY2020 bdpt Loss On Derivative Instruments Related To Convertible Notes
LossOnDerivativeInstrumentsRelatedToConvertibleNotes
132593 USD
CY2020 bdpt Beginning Balance
BeginningBalance
464024 USD
CY2020 bdpt Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
107000 USD
CY2020 bdpt Addition Of New Derivatives Recognized As Options Compensation
AdditionOfNewDerivativesRecognizedAsOptionsCompensation
0 USD
CY2020 bdpt Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
132593 USD
CY2020 bdpt Settled On Issuance Of Common Stock
SettledOnIssuanceOfCommonStock
-106167 USD
CY2020 bdpt Reclassification From Apic To Derivative Due To Tainted Instruments
ReclassificationFromAPICToDerivativeDueToTaintedInstruments
0 USD
CY2020 bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
229669 USD
CY2021 bdpt Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
153697 USD
CY2021 bdpt Settled On Issuance Of Common Stock
SettledOnIssuanceOfCommonStock
-565296 USD
CY2021 bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
-63478 USD
CY2021 bdpt Ending Balance
EndingBalance
557042 USD
CY2021Q4 bdpt Accrued Salary Payable
AccruedSalaryPayable
213333 USD
CY2020 bdpt Weighted Average Warrant Exercise Price Exercised
WeightedAverageWarrantExercisePriceExercised
0
CY2020 bdpt Number Of Warrants Outstanding Shares Expired
NumberOfWarrantsOutstandingSharesExpired
-200000 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
20000 USD
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2021 us-gaap Interest Paid
InterestPaid
1803 USD
CY2021 bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
153697 USD
CY2020 bdpt Loss On Derivative Instruments Related Convertible Notes
LossOnDerivativeInstrumentsRelatedConvertibleNotes
132593 USD
CY2021 bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
-63478 USD
CY2020 bdpt Gain Loss On Change In Fair Value Of The Derivative Liabilities
GainLossOnChangeInFairValueOfTheDerivativeLiabilities
229669 USD
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
90219 USD
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
362262 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
1000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50809780 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20829552 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
200000000 shares
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
72000 USD
CY2020 bdpt Warrant Term
WarrantTerm
P2Y
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
200000 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.10
CY2020 bdpt Class Of Warrant Or Right Outstanding Exercise Price Per Share
ClassOfWarrantOrRightOutstandingExercisePricePerShare
0
CY2020 us-gaap Interest Paid
InterestPaid
2628 USD
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
33715 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
77715 USD
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
5241 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
3438 USD
CY2021 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
CY2021 bdpt Term Of Notes Payable
TermOfNotesPayable
P1Y
CY2021 bdpt Accrued Salary Forgiven
AccruedSalaryForgiven
46667 USD
CY2021Q4 bdpt Salary Payable To Related Party
SalaryPayableToRelatedParty
166667 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
155988 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
64079 USD
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
155988 USD
CY2020Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
64079 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
270108 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
426096 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
270108 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
1286000 USD
CY2021 bdpt Articles Of In Corporation Description
ArticlesOfInCorporationDescription
On January 26, 2022, the Company amended its articles of incorporation to increase its authorized common shares from 200,000,000 to 750,000,000; this increase will be effective March 19, 2022

Files In Submission

Name View Source Status
0001640334-22-000689-index-headers.html Edgar Link pending
0001640334-22-000689-index.html Edgar Link pending
0001640334-22-000689.txt Edgar Link pending
0001640334-22-000689-xbrl.zip Edgar Link pending
bdpt-20211231.xsd Edgar Link pending
bdpt-20211231_cal.xml Edgar Link unprocessable
bdpt-20211231_def.xml Edgar Link unprocessable
bdpt-20211231_lab.xml Edgar Link unprocessable
bdpt-20211231_pre.xml Edgar Link unprocessable
bdpt_10k.htm Edgar Link pending
bdpt_10kimg1.jpg Edgar Link pending
bdpt_10k_htm.xml Edgar Link completed
bdpt_ex311.htm Edgar Link pending
bdpt_ex312.htm Edgar Link pending
bdpt_ex321.htm Edgar Link pending
bdpt_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending